nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ORM1—bile—gallbladder cancer	0.0543	0.332	CbGeAlD
Vemurafenib—ORM1—gall bladder—gallbladder cancer	0.0151	0.0922	CbGeAlD
Vemurafenib—ALB—gall bladder—gallbladder cancer	0.0132	0.0809	CbGeAlD
Vemurafenib—RAF1—epithelium—gallbladder cancer	0.0113	0.0691	CbGeAlD
Vemurafenib—RAF1—pancreas—gallbladder cancer	0.0101	0.0616	CbGeAlD
Vemurafenib—BRAF—liver—gallbladder cancer	0.00961	0.0588	CbGeAlD
Vemurafenib—BRAF—lymph node—gallbladder cancer	0.00737	0.0451	CbGeAlD
Vemurafenib—RAF1—liver—gallbladder cancer	0.0064	0.0392	CbGeAlD
Vemurafenib—RAF1—lymph node—gallbladder cancer	0.00491	0.03	CbGeAlD
Vemurafenib—ORM1—liver—gallbladder cancer	0.00442	0.027	CbGeAlD
Vemurafenib—ALB—liver—gallbladder cancer	0.00388	0.0237	CbGeAlD
Vemurafenib—ORM1—lymph node—gallbladder cancer	0.00339	0.0207	CbGeAlD
Vemurafenib—ABCC1—liver—gallbladder cancer	0.0032	0.0196	CbGeAlD
Vemurafenib—ALB—lymph node—gallbladder cancer	0.00297	0.0182	CbGeAlD
Vemurafenib—ABCG2—liver—gallbladder cancer	0.00265	0.0162	CbGeAlD
Vemurafenib—CYP1A2—liver—gallbladder cancer	0.00255	0.0156	CbGeAlD
Vemurafenib—ABCC1—lymph node—gallbladder cancer	0.00245	0.015	CbGeAlD
Vemurafenib—ABCG2—lymph node—gallbladder cancer	0.00203	0.0124	CbGeAlD
Vemurafenib—CYP3A4—liver—gallbladder cancer	0.00184	0.0113	CbGeAlD
Vemurafenib—CYP2D6—liver—gallbladder cancer	0.00182	0.0111	CbGeAlD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	0.000924	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—NRAS—gallbladder cancer	0.000924	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—ERBB2—gallbladder cancer	0.000923	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—ERBB2—gallbladder cancer	0.000923	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—ERBB2—gallbladder cancer	0.000918	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Insulin receptor—NRAS—gallbladder cancer	0.000917	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—ERBB2—gallbladder cancer	0.000914	0.00109	CbGpPWpGaD
Vemurafenib—BRAF—PDGFR-beta signaling pathway—HRAS—gallbladder cancer	0.000914	0.00109	CbGpPWpGaD
Vemurafenib—RAF1—ErbB1 downstream signaling—EGFR—gallbladder cancer	0.000905	0.00108	CbGpPWpGaD
Vemurafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—gallbladder cancer	0.000903	0.00108	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.000898	0.00107	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—HRAS—gallbladder cancer	0.000886	0.00106	CbGpPWpGaD
Vemurafenib—RAF1—Retinoblastoma (RB) in Cancer—TP53—gallbladder cancer	0.000883	0.00106	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—KRAS—gallbladder cancer	0.000874	0.00104	CbGpPWpGaD
Vemurafenib—BRAF—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.000874	0.00104	CbGpPWpGaD
Vemurafenib—RAF1—PDGFR-beta signaling pathway—NRAS—gallbladder cancer	0.000864	0.00103	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.000861	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—IRS-mediated signalling—HRAS—gallbladder cancer	0.000861	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—ERBB2—gallbladder cancer	0.00086	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	0.00086	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—ERBB2—gallbladder cancer	0.00086	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—ErbB1 downstream signaling—KRAS—gallbladder cancer	0.000855	0.00102	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—ERBB2—gallbladder cancer	0.000852	0.00102	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.000849	0.00101	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—ERBB2—gallbladder cancer	0.000847	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—ERBB2—gallbladder cancer	0.000845	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—KRAS—gallbladder cancer	0.000842	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—ERBB2—gallbladder cancer	0.000841	0.00101	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.000837	0.001	CbGpPWpGaD
Vemurafenib—RAF1—IRS-related events—HRAS—gallbladder cancer	0.000837	0.001	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—BCL2—gallbladder cancer	0.000836	0.001	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—KRAS—gallbladder cancer	0.000836	0.000999	CbGpPWpGaD
Vemurafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—gallbladder cancer	0.000835	0.000998	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.000833	0.000996	CbGpPWpGaD
Vemurafenib—RAF1—IRS-related events triggered by IGF1R—HRAS—gallbladder cancer	0.00083	0.000992	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—HRAS—gallbladder cancer	0.000822	0.000983	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	0.000821	0.000982	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—EGFR—gallbladder cancer	0.000814	0.000973	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.000814	0.000973	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—ERBB2—gallbladder cancer	0.000812	0.000971	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000809	0.000967	CbGpPWpGaD
Vemurafenib—RAF1—Insulin receptor signalling cascade—HRAS—gallbladder cancer	0.000808	0.000966	CbGpPWpGaD
Vemurafenib—RAF1—TNF alpha Signaling Pathway—HRAS—gallbladder cancer	0.000808	0.000966	CbGpPWpGaD
Vemurafenib—RAF1—IGF1R signaling cascade—HRAS—gallbladder cancer	0.000808	0.000966	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—KRAS—gallbladder cancer	0.000795	0.00095	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Insulin receptor—KRAS—gallbladder cancer	0.00079	0.000944	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—NRAS—gallbladder cancer	0.000785	0.000938	CbGpPWpGaD
Vemurafenib—RAF1—B Cell Receptor Signaling Pathway—HRAS—gallbladder cancer	0.000774	0.000926	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.000763	0.000912	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—ERBB2—gallbladder cancer	0.000762	0.00091	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—TP53—gallbladder cancer	0.00076	0.000908	CbGpPWpGaD
Vemurafenib—RAF1—Integrin-mediated Cell Adhesion—HRAS—gallbladder cancer	0.000756	0.000903	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—KEAP1—gallbladder cancer	0.000756	0.000903	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—TP53—gallbladder cancer	0.000754	0.000901	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—NRAS—gallbladder cancer	0.000751	0.000897	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—NRAS—gallbladder cancer	0.000751	0.000897	CbGpPWpGaD
Vemurafenib—RAF1—PDGFR-beta signaling pathway—KRAS—gallbladder cancer	0.000744	0.000889	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR—HRAS—gallbladder cancer	0.000743	0.000888	CbGpPWpGaD
Vemurafenib—BRAF—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.000743	0.000888	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—NRAS—gallbladder cancer	0.000739	0.000883	CbGpPWpGaD
Vemurafenib—RAF1—Senescence and Autophagy in Cancer—HRAS—gallbladder cancer	0.000727	0.000869	CbGpPWpGaD
Vemurafenib—RAF1—ErbB1 downstream signaling—HRAS—gallbladder cancer	0.000727	0.000869	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.000724	0.000865	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000721	0.000862	CbGpPWpGaD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—HRAS—gallbladder cancer	0.000716	0.000856	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—EGFR—gallbladder cancer	0.000715	0.000855	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Interleukins—HRAS—gallbladder cancer	0.000711	0.000849	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—NRAS—gallbladder cancer	0.000706	0.000844	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—NRAS—gallbladder cancer	0.000702	0.000839	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—NRAS—gallbladder cancer	0.000699	0.000835	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—NRAS—gallbladder cancer	0.000695	0.000831	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000692	0.000827	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—EGFR—gallbladder cancer	0.000684	0.000818	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—EGFR—gallbladder cancer	0.000684	0.000818	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—NRAS—gallbladder cancer	0.000682	0.000815	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—HRAS—gallbladder cancer	0.000676	0.000808	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—KRAS—gallbladder cancer	0.000675	0.000807	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—EGFR—gallbladder cancer	0.000673	0.000805	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by Insulin receptor—HRAS—gallbladder cancer	0.000671	0.000802	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.000659	0.000788	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.000659	0.000788	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	0.000654	0.000782	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—NRAS—gallbladder cancer	0.000654	0.000782	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—NRAS—gallbladder cancer	0.000654	0.000782	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—HRAS—gallbladder cancer	0.000654	0.000781	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—NRAS—gallbladder cancer	0.000648	0.000775	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—KRAS—gallbladder cancer	0.000646	0.000772	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	0.000646	0.000772	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—NRAS—gallbladder cancer	0.000644	0.00077	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—EGFR—gallbladder cancer	0.000643	0.000769	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	0.000643	0.000768	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—EGFR—gallbladder cancer	0.00064	0.000765	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	0.00064	0.000765	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—NRAS—gallbladder cancer	0.00064	0.000765	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—EGFR—gallbladder cancer	0.000637	0.000761	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—KRAS—gallbladder cancer	0.000636	0.00076	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—EGFR—gallbladder cancer	0.000634	0.000757	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—TP53—gallbladder cancer	0.000633	0.000756	CbGpPWpGaD
Vemurafenib—RAF1—PDGFR-beta signaling pathway—HRAS—gallbladder cancer	0.000632	0.000756	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000627	0.00075	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.000623	0.000745	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.000621	0.000743	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—ERBB4—gallbladder cancer	0.000616	0.000737	CbGpPWpGaD
Vemurafenib—BRAF—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000613	0.000732	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—KRAS—gallbladder cancer	0.000607	0.000726	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—KRAS—gallbladder cancer	0.000604	0.000722	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.000604	0.000722	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—KRAS—gallbladder cancer	0.000601	0.000719	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—KRAS—gallbladder cancer	0.000598	0.000715	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—EGFR—gallbladder cancer	0.000596	0.000712	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—EGFR—gallbladder cancer	0.000596	0.000712	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.000596	0.000712	CbGpPWpGaD
Vemurafenib—ALB—Folate Metabolism—TP53—gallbladder cancer	0.000593	0.000709	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—ERBB4—gallbladder cancer	0.000592	0.000707	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—EGFR—gallbladder cancer	0.000591	0.000706	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.000587	0.000702	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—EGFR—gallbladder cancer	0.000587	0.000702	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—ERBB2—gallbladder cancer	0.000586	0.0007	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—EGFR—gallbladder cancer	0.000585	0.0007	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—EGFR—gallbladder cancer	0.000583	0.000697	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.000579	0.000693	CbGpPWpGaD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—gallbladder cancer	0.000577	0.00069	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by SCF-KIT—HRAS—gallbladder cancer	0.000574	0.000686	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—HRAS—gallbladder cancer	0.000564	0.000675	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—EGFR—gallbladder cancer	0.000563	0.000673	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	0.000563	0.000673	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.000563	0.000673	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—KRAS—gallbladder cancer	0.000563	0.000673	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000561	0.00067	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	0.00056	0.000669	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—KRAS—gallbladder cancer	0.000558	0.000667	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—KRAS—gallbladder cancer	0.000554	0.000663	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.000553	0.000661	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—KRAS—gallbladder cancer	0.000551	0.000658	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.000549	0.000657	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB4—HRAS—gallbladder cancer	0.000541	0.000646	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—ERBB3—gallbladder cancer	0.000533	0.000637	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—ERBB2—gallbladder cancer	0.00053	0.000634	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.00053	0.000633	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.00053	0.000633	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.000528	0.000631	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—TP53—gallbladder cancer	0.000522	0.000624	CbGpPWpGaD
Vemurafenib—RAF1—Insulin Signaling—HRAS—gallbladder cancer	0.000519	0.00062	CbGpPWpGaD
Vemurafenib—RAF1—Downstream signal transduction—HRAS—gallbladder cancer	0.000516	0.000617	CbGpPWpGaD
Vemurafenib—RAF1—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.000514	0.000614	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR—HRAS—gallbladder cancer	0.000514	0.000614	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—ERBB3—gallbladder cancer	0.000512	0.000612	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—HRAS—gallbladder cancer	0.000511	0.000611	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.00051	0.00061	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 signaling—HRAS—gallbladder cancer	0.000509	0.000608	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000499	0.000596	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.000482	0.000576	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—HRAS—gallbladder cancer	0.000481	0.000575	CbGpPWpGaD
Vemurafenib—BRAF—Disease—ERBB4—gallbladder cancer	0.000479	0.000573	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000479	0.000572	CbGpPWpGaD
Vemurafenib—RAF1—DAP12 interactions—HRAS—gallbladder cancer	0.000479	0.000572	CbGpPWpGaD
Vemurafenib—RAF1—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000479	0.000572	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—HRAS—gallbladder cancer	0.000474	0.000567	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—HRAS—gallbladder cancer	0.000471	0.000563	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000471	0.000563	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.00047	0.000562	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—HRAS—gallbladder cancer	0.000468	0.000559	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.000453	0.000542	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—HRAS—gallbladder cancer	0.000452	0.000541	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—NRAS—gallbladder cancer	0.000446	0.000533	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000434	0.000519	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000424	0.000507	CbGpPWpGaD
Vemurafenib—BRAF—Disease—ERBB3—gallbladder cancer	0.000414	0.000495	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.00041	0.00049	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—EGFR—gallbladder cancer	0.000406	0.000485	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—NRAS—gallbladder cancer	0.000403	0.000482	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.00039	0.000466	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—KRAS—gallbladder cancer	0.000384	0.000458	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—ERBB2—gallbladder cancer	0.000378	0.000452	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—EGFR—gallbladder cancer	0.000367	0.000439	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ERBB4—gallbladder cancer	0.000359	0.000429	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—KRAS—gallbladder cancer	0.000347	0.000415	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—BCL2—gallbladder cancer	0.000344	0.000411	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ERBB4—gallbladder cancer	0.000335	0.000401	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—ERBB2—gallbladder cancer	0.000334	0.000399	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—HRAS—gallbladder cancer	0.000333	0.000398	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000332	0.000396	CbGpPWpGaD
Vemurafenib—RAF1—Disease—ERBB4—gallbladder cancer	0.000331	0.000396	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—ERBB4—gallbladder cancer	0.000329	0.000393	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—HRAS—gallbladder cancer	0.000326	0.00039	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—ERBB2—gallbladder cancer	0.000321	0.000383	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ERBB3—gallbladder cancer	0.00031	0.000371	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—HRAS—gallbladder cancer	0.000295	0.000353	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ERBB3—gallbladder cancer	0.00029	0.000347	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—NRAS—gallbladder cancer	0.000288	0.000344	CbGpPWpGaD
Vemurafenib—RAF1—Disease—ERBB3—gallbladder cancer	0.000287	0.000343	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—ERBB3—gallbladder cancer	0.000284	0.00034	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—NRAS—gallbladder cancer	0.000282	0.000337	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—EGFR—gallbladder cancer	0.000262	0.000313	CbGpPWpGaD
Vemurafenib—BRAF—Disease—ERBB2—gallbladder cancer	0.00026	0.00031	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—NRAS—gallbladder cancer	0.000254	0.000304	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—KRAS—gallbladder cancer	0.000248	0.000296	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—NRAS—gallbladder cancer	0.000244	0.000292	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—KRAS—gallbladder cancer	0.000243	0.00029	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ERBB4—gallbladder cancer	0.000232	0.000277	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—EGFR—gallbladder cancer	0.000232	0.000277	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—EGFR—gallbladder cancer	0.000222	0.000266	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—KRAS—gallbladder cancer	0.000219	0.000262	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TP53—gallbladder cancer	0.000216	0.000258	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—HRAS—gallbladder cancer	0.000211	0.000252	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—KRAS—gallbladder cancer	0.00021	0.000251	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—HRAS—gallbladder cancer	0.000207	0.000247	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ERBB3—gallbladder cancer	0.000201	0.00024	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—BCL2—gallbladder cancer	0.0002	0.000239	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NRAS—gallbladder cancer	0.000198	0.000236	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ERBB2—gallbladder cancer	0.000195	0.000233	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—HRAS—gallbladder cancer	0.000186	0.000222	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ERBB2—gallbladder cancer	0.000182	0.000217	CbGpPWpGaD
Vemurafenib—BRAF—Disease—EGFR—gallbladder cancer	0.00018	0.000215	CbGpPWpGaD
Vemurafenib—RAF1—Disease—ERBB2—gallbladder cancer	0.00018	0.000215	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—HRAS—gallbladder cancer	0.000179	0.000213	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—ERBB2—gallbladder cancer	0.000178	0.000213	CbGpPWpGaD
Vemurafenib—BRAF—Disease—KRAS—gallbladder cancer	0.00017	0.000203	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—NRAS—gallbladder cancer	0.000162	0.000194	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NRAS—gallbladder cancer	0.000152	0.000182	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—NRAS—gallbladder cancer	0.000148	0.000177	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—EGFR—gallbladder cancer	0.000148	0.000176	CbGpPWpGaD
Vemurafenib—BRAF—Disease—HRAS—gallbladder cancer	0.000145	0.000173	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—KRAS—gallbladder cancer	0.000139	0.000167	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NRAS—gallbladder cancer	0.000138	0.000165	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NRAS—gallbladder cancer	0.000137	0.000163	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NRAS—gallbladder cancer	0.000135	0.000162	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—EGFR—gallbladder cancer	0.000135	0.000161	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—KRAS—gallbladder cancer	0.000131	0.000156	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—KRAS—gallbladder cancer	0.000127	0.000152	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EGFR—gallbladder cancer	0.000126	0.000151	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ERBB2—gallbladder cancer	0.000126	0.00015	CbGpPWpGaD
Vemurafenib—RAF1—Disease—EGFR—gallbladder cancer	0.000125	0.000149	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—EGFR—gallbladder cancer	0.000123	0.000148	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—KRAS—gallbladder cancer	0.000119	0.000142	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HRAS—gallbladder cancer	0.000119	0.000142	CbGpPWpGaD
Vemurafenib—RAF1—Disease—KRAS—gallbladder cancer	0.000118	0.000141	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—KRAS—gallbladder cancer	0.000117	0.000139	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TP53—gallbladder cancer	0.000116	0.000139	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—HRAS—gallbladder cancer	0.000111	0.000133	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HRAS—gallbladder cancer	0.000108	0.000129	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TP53—gallbladder cancer	0.000106	0.000127	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HRAS—gallbladder cancer	0.000101	0.000121	CbGpPWpGaD
Vemurafenib—RAF1—Disease—HRAS—gallbladder cancer	0.0001	0.00012	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—HRAS—gallbladder cancer	9.91e-05	0.000118	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NRAS—gallbladder cancer	9.57e-05	0.000114	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EGFR—gallbladder cancer	8.72e-05	0.000104	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—KRAS—gallbladder cancer	8.24e-05	9.85e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TP53—gallbladder cancer	7.32e-05	8.75e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HRAS—gallbladder cancer	7e-05	8.37e-05	CbGpPWpGaD
